Labcorp Q3 FY26: where the revenue came from and where it went
The whole income statement of Labcorp for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2026
- Reported
- Oct 30, 2026
Revenue$3.81B
+7% year over year
Gross profit$1.11B
29% margin
Operating profit$0.40B
11% margin
Net profit$0.26B
7% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 3.81 | 100% | +7% |
| Diagnostics | 2.95 | 77% | +6% |
| Biopharma laboratory | 0.87 | 23% | +8% |
| Cost of revenue | −2.70 | 71% | |
| Gross profit | 1.11 | 29% margin | +0pp |
| SG&A | −0.61 | 16% | +1pp |
| Other | −0.10 | 3% | +0pp |
| Operating profit | 0.40 | 11% margin | −1pp |
| Interest & other costs | −0.07 | ||
| Tax | −0.07 | ||
| Net profit | 0.26 | 7% margin | +0pp |
8 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest